Intravenously administered nitro-imidazole radiosensitizer and alkylat
ing anticancer compound CI-1010, designated as (2-bromoethyl)amino]met
hyl]-2-nitro-1H-imidazole-1 -ethanol monohydrobromide, causes multiorg
an toxicity in rodents, including retinal degeneration. This study det
ermined the potential of CI-1010 to induce similar effects in nonhuman
primates. One male and 1 female cynomolgus monkey were given single d
aily doses of CI-1010 intravenously for 5 consecutive days each week f
or 3 wk. Doses were escalated from 5 mg per kilogram of body weight in
week 1 to 40 and 60 mg/kg in week 3. Postdosing emesis occurred in bo
th monkeys at 5 mg/kg, and clinical signs at 40 and 60 mg/kg included
more pronounced emesis, reduced food consumption, pallor, weakness, an
d body weight loss. At study termination, both monkeys had markedly re
duced peripheral blood lymphocytes and moderately lowered erythrocyte,
hemoglobin, and hematocrit levels, which correlate with a decreased t
otal nucleated bone marrow cell count. At necropsy, the monkeys had pa
ncytic bone marrow hypocellularity, multiorgan lymphoid depletion, pan
creatic acinar cell apoptosis, testicular seminiferous tubular degener
ation, and bilateral multifocal retinal degeneration involving the pho
toreceptor and outer nuclear layers. Ultrastructurally, selected inner
and outer retinal rod segments were swollen and fragmented, a state a
ssociated with cytoplasmic condensation and pyknosis of the outer nucl
ear cell layer. Thus, CI-1010 induced toxicity of hematopoietic/lympho
id organs, retina, testes, and pancreas in monkeys, findings similar t
o those of previous studies in rodents.